Drug Target Review2024-04-30T12:00:33
The new organoids demonstrate a greater diversity of TECs in culture and are capable of maturing T cells.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-25T15:00:00
Sponsored by Yokogawa
2023-07-04T10:05:58
Sponsored by Revvity
2026-06-09T08:20:00
Contributor Steve Smith, Drug Target Review
2026-06-02T15:00:00
Sponsored by Danaher Life Sciences
2026-08-11T07:02:00
Contributor Professor Joseph C. Wu, Drug Target Review
2024-01-26T13:22:42
Sponsored by bit.bio
Site powered by Webvision Cloud